These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9002007)

  • 1. Prediction of articular destruction in rheumatoid arthritis: disease activity markers revisited.
    Coste J; Spira A; Clerc D; Paolaggi JB
    J Rheumatol; 1997 Jan; 24(1):28-34. PubMed ID: 9002007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of genetic information for predicting radiographic damage in rheumatoid arthritis.
    Chen JJ; Mu H; Jiang Y; King MC; Thomson G; Criswell LA
    J Rheumatol; 2002 Oct; 29(10):2068-73. PubMed ID: 12375313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical activity after 12 weeks of treatment with nonbiologics in early rheumatoid arthritis may predict articular destruction 2 years later.
    Ichikawa Y; Saito T; Yamanaka H; Akizuki M; Kondo H; Kobayashi S; Oshima H; Kawai S; Hama N; Yamada H; Mimori T; Amano K; Tanaka Y; Matsuoka Y; Yamamoto S; Matsubara T; Murata N; Asai T; Suzuki Y;
    J Rheumatol; 2010 Apr; 37(4):723-9. PubMed ID: 20194455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985.
    Pincus T; Sokka T; Kautiainen H
    Arthritis Rheum; 2005 Apr; 52(4):1009-19. PubMed ID: 15818706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
    Verhoef CM; van Roon JA; Vianen ME; Bijlsma JW; Lafeber FP
    J Rheumatol; 2001 Sep; 28(9):1960-6. PubMed ID: 11550960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.
    Welsing PM; van Gestel AM; Swinkels HL; Kiemeney LA; van Riel PL
    Arthritis Rheum; 2001 Sep; 44(9):2009-17. PubMed ID: 11592361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis.
    D'Elia HF; Larsen A; Mattsson LA; Waltbrand E; Kvist G; Mellström D; Saxne T; Ohlsson C; Nordborg E; Carlsten H
    J Rheumatol; 2003 Jul; 30(7):1456-63. PubMed ID: 12858441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
    Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
    Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
    Lard LR; Roep BO; Toes RE; Huizinga TW
    J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis.
    Al-Matar MJ; Petty RE; Tucker LB; Malleson PN; Schroeder ML; Cabral DA
    Arthritis Rheum; 2002 Oct; 46(10):2708-15. PubMed ID: 12384930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate.
    Yazici Y; Pincus T; Kautiainen H; Sokka T
    J Rheumatol; 2004 Sep; 31(9):1723-6. PubMed ID: 15338490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis.
    van der Helm-van Mil AH; van der Kooij SM; Allaart CF; Toes RE; Huizinga TW
    Ann Rheum Dis; 2008 Jun; 67(6):769-74. PubMed ID: 17965124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis.
    Kuiper S; van Gestel AM; Swinkels HL; de Boo TM; da Silva JA; van Riel PL
    J Rheumatol; 2001 Aug; 28(8):1809-16. PubMed ID: 11508583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
    Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
    Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
    Clarke AE; St-Pierre Y; Joseph L; Penrod J; Sibley JT; Haga M; Genant HK
    J Rheumatol; 2001 Nov; 28(11):2416-24. PubMed ID: 11708412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.